Innovations for vaccines against helminth infections

Photo by Noor Kuhlemaijer, LUMC

WORMVACS2.0 will establish an effective pipeline for helminth vaccine development focusing on schistosomes and hookworms, to support control and elimination of some of the world’s most devastating and persistent Neglected Tropical Diseases (NTDs).

WORMVACS2.0 is funded by Horizon Europe and will run between September 2023 and August 2028.

To learn more about the project’s quest to better understand helminth infections and create vaccine for them, watch this video featuring the Leiden University Medical Center team:

START

01 Sep ‘23

DURATION

01 Sep ‘23 - 31 Aug ‘28

HORIZON EUROPE: €6,881,714.99

SERI: €541,160

UKRI: £532,296

12 PARTNERS

from Europe, Africa, Australia, United States

Team

The WORMVACS2.0 consortium includes world-leading experts in the areas of vaccine target discovery and development, pre-clinical and clinical models of helminth infections, helminth immunology and vaccine/antigen production platform technologies. The combined expertise perfectly places the team to reach the project´s ambitious objectives of establishing an effective pipeline to support helminth vaccine development to enable control and elimination of the world’s most devastating helminth infections.